Perspectives

Channel NewsAsia’s flagship panel discussion programme ‘Perspectives’ (2017) into its 6th year, filmed on location in front of an audience, brings together senior experts from a multitude of backgrounds - academia, industry, governments and NGOs - to debate their views on key current affairs issues. In-depth analyses, engaging views and insightful comments plus thought provoking critical thinking questions from the audience - our experts will connect the dots surrounding the headlines and controversies, and will discuss the ‘why’s and the ‘what if’s of global events and ‘how’ they’re likely to shape our future.

Patients in Pain, Pain Treatment in Palliative Care

Recording Date: Friday 12 May 2017

Venue: Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by: 9.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Raman Singh

CEO, Mundipharma Pte Ltd


Raman Singh is CEO of Mundipharma, a network of independent associated companies that operate across Asia-Pacific, Latin America the Middle East and Africa. He has led the organisation since October 2011.

Among numerous recent accolades, Mr Singh has featured in the top five on the Medicine Maker’s ‘Power List’ and Mundipharma won ‘Emerging Markets Company of the Year’ at the Scrip Awards in 2016.

Prior to this, he was the vice-president of commercial operations for emerging markets at GlaxoSmithKline, based in London, where he was in charge of overseeing all aspects of the brand’s commercial operations across its emerging markets.

Mr Singh has previously held positions in Abbott as the regional director in Australia and New Zealand, and general manager for Korea. He has also held various sales, marketing and strategy positions in Bayer.

Mr Singh holds an MBA from Thunderbird School of Global Management.

Ong Yew Jin

Medical Director, Singapore Cancer Society

Ong Yew Jin

Medical Director, Singapore Cancer Society


In his capacity as Medical Director at Singapore Cancer Society (SCS), Dr Ong Yew Jin works towards improving the quality of clinical care to position SCS as an organisation providing quality care. He also focuses on strategically developing an integrated and holistic model of care as part of the cancer care continuum.

Dr Ong is a Specialist in Palliative Medicine, and has clinical oversight of the SCS Hospice Care and Psychosocial Service departments, and the SCS Cancer Rehabilitation Centre, the first one-stop community-based cancer rehabilitation centre in Singapore, which was officially opened in October 2016.

Dr Ong finds fulfilment in being able to work closely with a team of dedicated healthcare professionals, and to grow as a person, while coping with the intricacies of grief and loss together with peers, patients and their families. Dr Ong joined SCS in January 2015 from Assisi Hospice where he was Head of Medical Services. He graduated from NUS medical school in 1998 and initially trained as an emergency medicine physician. A personal experience of caring for an ill loved one led him to realise the need for diverse skills and resources to provide good care at the end of life and particularly at home. This ultimately spurred him to join Assisi Hospice in Oct 2005 and to specialise in palliative care.

Outside of work, Dr Ong enjoys spending time in Phnom Penh with other volunteers and staff at St Elisabeth Sick Shelter (caring mainly for patients with cancer), as well as working with students from Singapore and Cambodia to run a health and education project in Poipet, Cambodia (Project Battambang).

Dr Noreen Chan

Head & Senior Consultant, Division of Palliative Care, National University Cancer Institute, Singapore
Asst Prof, Dept of Medicine, NUS Yong Loo Lin School of Medicine

Dr Noreen Chan

Head & Senior Consultant, Division of Palliative Care, National University Cancer Institute, Singapore
Asst Prof, Dept of Medicine, NUS Yong Loo Lin School of Medicine


Dr Noreen Chan obtained her medical degrees from the University of London and Royal College of Physicians UK, and completed advanced specialty training with the Sydney Institute of Palliative Medicine, Australia. She was Medical Director and CEO of Dover Park Hospice before joining the National University Cancer Institute, Singapore (NCIS), where she is now Senior Consultant in Palliative Medicine and ACP (Advance Care Planning) Lead for the National University Hospital.

Dr Neo Han Yee

Consultant, Department of Palliative Medicine, Tan Tock Seng Hospital
Singapore Hospice Council

Dr Neo Han Yee

Consultant, Department of Palliative Medicine, Tan Tock Seng Hospital
Singapore Hospice Council


Dr Neo is a medical physician from Tan Tock Seng Hospital (a member of Singapore Hospice Council). He graduated from NUS in 2003 and underwent basic specialist training in Internal Medicine. After which, he took on and completed advanced specialist training in Geriatrics Medicine and Palliative Medicine. Dr Neo now works as a consultant in Tan Tock Seng Hospital, and spends most of his time caring for terminally ill patients. He has a keen interest in clinical ethics, in particular, those pertaining to medical care at the end-of-life. He is also the Deputy Co-Chairperson of the hospital's Clinical Ethics Committee.

The War on Cancer in Asia

Recording Date: Friday 12 May 2017

Venue: Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by 9.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Dr Lim Siew Eng

Senior Consultant, Department of Haematology-Oncology, National University Cancer
Institute, Singapore (NCIS)

Dr Lim Siew Eng

Senior Consultant, Department of Haematology-Oncology, National University Cancer
Institute, Singapore (NCIS)


Feon is Vice President of LinkedIn’s Talent and Learning Solutions business, responsible for helping clients to engage, upskill, retain top talents across APAC.

She joined LinkedIn in January 2013, and oversees a sales organization and go-to-market strategy in the diverse set of geographies in her coverage. A seasoned business leader, Feon is particularly interested in nurturing talents, and takes an active interest in building high performance sales teams and empowering her teams to deliver outstanding results.

Prior to joining LinkedIn, Feon spent more than 13 years at Gartner in various leadership roles, where she was most recently its regional vice-president overseeing relationships with strategic client accounts across the Asia Pacific region.

Feon holds a Bachelor degree (Business) from the Nanyang Technological University in Singapore.

To view Feon’s detailed profile, click on: https://sg.linkedin.com/in/feonang

A/Prof Teoh Yee Leong

Chief Executive Officer, Singapore Clinical Research Institute
Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore

A/Prof Teoh Yee Leong

Chief Executive Officer, Singapore Clinical Research Institute
Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore
A/Prof Teoh is a Public Health Physician with extensive expertise in the area of clinical research and public health. He obtained his MBBS in 1994 and MMed (Public Health Medicine) in 2003 from National University of Singapore. As CEO of Singapore Clinical Research Institute, an Academic Research Organisation within the Ministry of Health Holdings, Singapore, he is involved in spearheading the clinical research initiatives in Singapore and building research partnerships with various public and private organizations in the region. He is also an Adjunct Associate Professor with Saw Swee Hock School of Public Health, National University of Singapore.

Prior to his appointment as CEO of SCRI in May 2013, he was Vice-President and General Manager for Emergent Biosolutions Asia Pacific. In that role, he was involved in the development of various vaccines and immunotherapeutic for this Biotech organisation. He was also Director, Clinical Research and Medical Affairs for GlaxoSmithKline Singapore, Malaysia and Brunei from 2000 to 2005 where he conducted one of the largest Phase 3 clinical trials in Singapore involving more than 6,000 subjects for a Rotavirus vaccine.

A/Prof Teoh’s previous other senior appointments included being Assistant Commissioner of Public Health (Ministry of the Environment), Physician and Head, Jurong Polyclinic (National Healthcare Group Polyclinics) and Infectious Disease Epidemiologist (Communicable Disease Centre, Tan Tock Seng Hospital, Singapore). He has been involved in many epidemiological studies and clinical trials in Singapore both as Principal Investigators and also as Pharmaceutical Sponsors in the last 15 years.

Dr Ruby Yun-Ju Huang

Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore

Dr Ruby Yun-Ju Huang

Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Dr Ruby Yun-Ju Huang was trained as a gynaecological oncologist in Taiwan, but has made the unusual step of pursuing a career as a Clinician Scientist. She has long-standing interest in epithelial-mesenchymal transition (EMT) which was the focus of her PhD, establishing the link between the responsiveness to growth factor-induced colony dispersal and epithelial and mesenchymal phenotypes in ovarian cancer cells. She co-discovered the presence of five molecular subtypes in epithelial ovarian cancer that exhibit different epithelial, mesenchymal, and stem cell-like characteristics. The overall aim of her research is to develop novel therapeutics for ovarian cancer through a better understanding of the specific driving mechanisms for each molecular subtype. To do this she has established an ovarian cancer research pipeline including preclinical discovery and translational phases incorporating novel preclinical models (cell lines, PDXs) and large scale genomics data with close collaboration with her clinical colleagues. She has recently been appointed as Director of the Translational Centre for Development and Research (Transcender) at the National University Health System (NUHS). Her goal is to bring her experience in ovarian cancer translational research to a boarder community to facilitate the progress from discoveries to applications.

An Innovative Health Climate

Recording Date: Monday 15 May 2017

Venue:Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by 9.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Professor Carolyn Lam

Professor, Programme in Cardiovascular & Metabolic Disorders
Duke-NUS Medical School

Professor Carolyn Lam

Professor, Programme in Cardiovascular & Metabolic Disorders
Duke-NUS Medical School


Prof Carolyn Lam is a Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore; Professor of SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme; and Chairperson of the Asia Pacific Association of Women’s Cardiovascular Disease. She graduated from the Faculty of Medicine, National University of Singapore, completed advanced specialty training in Cardiology in Singapore, and pursued her Research Fellowship at the Cardiorenal Laboratory, Heart Failure Fellowship at the Division of Cardiovascular Diseases, and Advanced Cardiology and Master of Biomedical Sciences at Mayo Clinic, Rochester MN. She further obtained training in clinical and genetic epidemiology at the Framingham Heart Study in Boston, MA before returning to Singapore in 2010 on the National Medical Research Council’s Clinician Scientist Award.

Prof Lam’s clinical sub-specialty is heart failure, and she is recognized globally for her expertise in heart failure with preserved ejection fraction. She also has expertise in women’s cardiovascular disease, hemodynamics, echocardiography, biomarkers and clinical trials. She started the first Heart Failure with Preserved Ejection Fraction Programme and Women’s Heart Health Clinic in Singapore, was awarded the L’Oreal Women In Science Award (2012) for her work in women’s cardiovascular disease, was named an InterAcademy Medical Panel Young Physician Leader at the World Health Summit in Berlin (2012), and won the award for the Junior Chamber International (JCI) Ten Outstanding Young Persons of the World for 2014 –Singapore (2014).

She is the Programme Lead of the Asian neTwork for Translational Research and Cardiovascular Trials (ATTRaCT) – an A*STAR Biomedical Research Council-funded research platform; and principal investigator of an ongoing nation-wide heart failure study in Singapore (the Singapore Heart Failure Outcomes and Phenotypes [SHOP] study), a multinational Asian study of heart failure across 11 Asian countries (Asian Sudden Cardiac Death in Heart Failure [ASIAN-HF] study), as well as a multinational Asian registry of diabetes (Asian Diabetes Outcomes Registry [ADORE]) in collaboration with the American College of Cardiology’s Diabetes Collaborative Registry. She serves as a consultant on several global advisory boards for cardiovascular disease, as a member of the Executive Committees of global heart failure trials, and as an Associate Editor for Circulation and European Journal of Heart Failure.

Finally Prof Lam is seen regularly on television as the Resident Doctor of the health programme “Body and Soul” by MediaCorp Singapore, and heard weekly around the world on the podcast “Circulation On The Run” by the American Heart Association.

Dr Eric Wong

Group Chief Medical Informatics Officer
National Healthcare Group

Dr Eric Wong

Group Chief Medical Informatics Officer
National Healthcare Group


Dr Eric Wong is currently the Group Chief Medijcal Informatics Officer (CMIO) for National Healthcare Group and the CMIO of Tan Tock Seng Hospital (TTSH), Singapore. He is responsible for the overall vision, planning, and implementation of its healthcare IT capabilities.

During his tenure as CMIO, Dr Wong has been pivotal in integrating technology with medicine for optimised patient safety and care delivery. He has led numerous clinical IT initiatives, including outpatient electronic prescription, electronic clinical documentation, closed loop inpatient medication management systems, clinical decision support system, and electronic nursing orders. In addition to his work within the National Healthcare Group, Dr Wong is involved in national healthcare IT strategic planning, including the National Health IT Master Plan and other workgroups. He currently serves in the Ministry of Health's Chief Medical Informatics Officer Council, providing guidance and leadership to Singapore's national health IT projects.

Dr Wong continues to serve patients as a Consultant in the Emergency Department of TTSH.

In addition to his clinical and informatics work, Dr Wong is actively involved in teaching post-graduate medical students at the Yong Loo Lin School of Medicine, Singapore. He received the Clinical Leadership in Research Award in 2011.

Adrian Lee

Vice President and Head, Customer Systems Group
Parkway Pantai

Adrian Lee

Vice President and Head, Customer Systems Group
Parkway Pantai


Mr Adrian Lee is the Vice President and Head of Customer Systems Group in Parkway Pantai Limited. Parkway Pantai Limited is a fully owned subsidiary of IHH Healthcare Berhad, the second largest healthcare group in the world by market capitalisation. In this position, he drives innovation and develops new digital capabilities, while being responsible for the advocacy and management of customer experience, as well as engagement across Parkway’s value chain, which includes Patients, Physicians and Business Partners.

Prior to joining Parkway Pantai Limited, Mr Lee served as the Managing Director for RCI Asia Pacific, a subsidiary of Wyndham Worldwide Corporation, where he led the regional business out of Singapore.

With over 25 years of experience in management and strategy, Mr Lee’s expertise lies in building and maintaining long-term operational plans, improving overall sales performance, establishing and nurturing key customer as well as business relationships. Mr Lee holds a Master of Science in Defence Technology from Cranfield University in the UK, and a BA in Chemical Engineering from the National University of Singapore.

Living Well, Aging Well - Improving Quality of Life for the Aged

Recording Date: Monday 22 May 2017

Venue:Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by 9.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Dr Jeyaindran Sinnadurai

Deputy Director General of Health (Medical)
Ministry of Health Malaysia

Dr James Low

Senior Consultant, Department of Geriatric Medicine and Palliative Care, Khoo Teck Puat Hospital
Singapore Hospice Council

Dr James Low

Senior Consultant, Department of Geriatric Medicine and Palliative Care, Khoo Teck Puat Hospital
Singapore Hospice Council


Dr James Low main areas of interest are in Geriatric Medicine, Palliative Care and Communications in the hospital. He is a Senior Consultant, at Khoo Teck Puat Hospital (a member of Singapore Hospice Council). Dr Low chairs the Khoo Teck Puat Hospital Clinical Ethics Committee and he is also the Director of Long Term Care. His interest in education has led him to be appointed adjunct at Lee Kong Chian School of Medicine and he is currently the Programme Lead for Education Research at the Geriatric Education and Research Institute, Singapore.

Chin Wei Jia

Group CEO, Health Management International

Chin Wei Jia

Group CEO, Health Management International


Group CEO of Health Management International Ltd (HMI), Ms Chin concurrently is the Managing Director of its two hospitals in Malaysia, Mahkota Medical Centre in Malacca and Regency Specialist Hospital in Iskandar Malaysia, Johor.

She is responsible for the overall development of HMI’s healthcare and education businesses overseeing strategic planning and business development. Joined HMI in 2002 as a Management Trainee, she played a key role in developing HMI. Today, it is a SGX mainboard-listed company with regional presence in Malaysia, Indonesia and Cambodia.

She led the establishment of HMI’s Medisave-accredited patient service centre (that enables Singaporeans to use their Medisave for hospitalisation and day surgeries overseas.

As CEO of Regency (2012-2016), she led the hospital to become one of the fastest growing private hospitals in Malaysia. She played a strategic role developing Mahkota into a multiple-award winning tertiary hospital - a recognised name in medical tourism. She contributed to the launch of HMI Institute of Health Sciences in 2002, and played a central role in its appointment as a Singapore Workforce Development Agency (WDA) Continuing Education and Training Centre since 2009. A member of the Malaysia Singapore Business Council (MSBC) Services Committee, she also participates as a speaker in healthcare conferences and seminars in SE Asia. Graduated from Johns Hopkins University,US with a Masters of Arts in International Relations and obtained her Bachelor of Arts (Summa Cum Laude), double degree in Economics and International Relations from Boston University, US.

Healthcare Beyond Treatment - Empowering Caregivers

Recording Date: Monday 29 May 2017

Venue:Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by 9.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Assoc Prof Lee Kheng Hock

President, College of Family Physicians Singapore

Assoc Prof Lee Kheng Hock

President, College of Family Physicians Singapore


A/Prof Lee obtained his medical degree at the National University of Singapore in 1987. He holds the Master of Medicine Degree in Family Medicine (1993), Diploma in Practical Dermatology (UK) the Fellow of the College of Family Physicians Singapore (2000) and the Fellow of Academy of Medicine Singapore (2014). A/Prof Lee served continuously as a Council Member of the College of Family Physicians since 1993 and was the Censor-in-Chief (Chief Examiner) of the College of Family Physicians Singapore from 2005 to 2009. He is presently the President of the College of Family Physicians Singapore and the Vice-Chairman of the Chapter of Family Medicine Physicians, Academy of Medicine Singapore. He serves in various national level committees that promote training and professionalism in Singapore. He is an examiner in various national level examinations including the Master of Medicine (Family Medicine) Exams, the Graduate Diploma in Family Medicine, the Fellowship of the College of Family Physicians Singapore and the Advanced Practice Nurse Examinations.

His area of interest is in health assessment, physician training, integrated care and health services research. He is the Clerkship Director of the Family Medicine Clerkship and the College Master of the Sir Gordon Arthur Ransome Student Advisory College of the school. A/Prof Lee is active in promoting research and holds leadership roles in various research platforms including the SingHealth DukeNUS Health Services Research Institute.

Before returning to the public sector in 2006, A/Prof Lee worked for 10 years as a clinician leader in a private group practice. Presently, he is a Senior Consultant in the Department of Family Medicine and Continuing Care in the Singapore General Hospital where he served as the founding Head of Department for 9 years from 20016 to 2015. His present clinical duties include providing care to hospitalized patients and patients at the specialist outpatient clinic of our hospital. A/Prof Lee also holds leadership roles in administration. He is concurrently the Director (Medical) at Bright Visions Hospital and the Director of the Office of Integrated Care at the Singapore General Hospital. A/Prof Lee is presently the clinician lead in various care integration initiatives at the SingHealth Regional Health System.

Tin Pei Ling

Member of Parliament, Singapore
Deputy Chairperson, Social and Family Development GPC

Tin Pei Ling

Member of Parliament, Singapore
Deputy Chairperson, Social and Family Development GPC


Pei Ling is a second-term elected Member of Parliament in Singapore. She serves on the Public Accounts Committee (13th Parliament). She also serves on the Government Parliamentary Committee for Law/Home Affairs (2011-2015), Health (2011 – present), and Social & Family Development (2015 – present, Dy Chairperson). Pei Ling is currently an adviser to two unions – SISEU and SSSU – and various temples and clan associations.

In Parliament, Pei Ling actively championed issues pertaining to public healthcare, elderly, youth, and women. She also represented Singapore on various international platforms, including state visits, parliamentary exchanges and a visit to the European Union to promote the EU-Singapore Free Trade Agreement and other related matter.

Pei Ling co-authored PAP Women’s Wing’s position paper 2016, specifically in the areas of Family & Caregiving and Smart Women in Smart Nation. Key ideas included freeing up capacity and giving options to working mothers (and fathers) who also have to care for their loved ones through innovations and leveraging technology. In April 2017, Pei Ling also moved a substantive motion with fellow Parliamentary colleagues. It was titled “Aspirations of Women” in Parliament to seek the House’s affirmation of the familial, social and economic contributions of Singapore women and its support for them to fulfil their family and career aspirations and to be future-ready’. The debate covered the need for greater support for caregivers so as to create capacity and offer options to women (and men) so that they can pursue other aspirations in life as well. The motion was passed unanimously in Parliament.

Prior to entering Parliament in 2011, Pei Ling was a business and management consultant in Ernst & Young Advisory with years of experience in strategy formulation & articulation, organization excellence, industry studies, channel strategies, competency frameworks, business process reviews and transformation change management within large client organisations, as well as in service excellence for large retail firms. Currently, Pei Ling is Director for Corporate Strategy with Jing King Tech Group. Pei Ling was also an active youth and grassroots leader for seven years prior to 2011.

Pei Ling holds a Master of Business Administration from leading business school of the University of Chicago (Chicago Booth). She also holds a Bachelor of Social Sciences (Honours) (University Scholars Programme) from the National University of Singapore.

A/Prof Chin Jing Jih

Deputy Chairman, Medical Board
Senior Consultant Geriatrician,
Chairman, Division of Integrated and Community Care
Director, Institute of Geriatrics and Active Ageing
Tan Tock Seng Hospital, Singapore

A/Prof Chin Jing Jih

Deputy Chairman, Medical Board
Senior Consultant Geriatrician,
Chairman, Division of Integrated and Community Care
Director, Institute of Geriatrics and Active Ageing
Tan Tock Seng Hospital, Singapore


Dr Chin Jing Jih is Deputy Chairman, Medical Board and Senior Consultant Geriatrician at Tan Tock Seng Hospital, where he is also Chairman of the Division of Integrative and Community Care, a cluster of clinical departments tasked with integrating care between TTSH and the primary care, and community care services. He is also Assistant Dean for Integrated Care and Lead for Ethics and Professionalism at the Lee Kong Chian School of Medicine, where he is Adjunct Associate Professor. He is a Board member of Agency for Integrated Care and a Council member of Dover Park Hospice, and a member of the Medical Advisory Board of Ang Mo Kio-THK Hospital.

An Accessible Asia

Recording Date: Monday 29 May 2017

Venue:Mundipharma
12 Marina View, #22-01 Asia Square Tower 2 Singapore 018 961

Guests to be seated by 11.00am


Raman Singh

CEO, Mundipharma Pte Ltd

Dr Susann Roth

Senior Social Development Specialist,
Asian Development Bank

Dr Susann Roth

Senior Social Development Specialist,
Asian Development Bank


The Asian Development Bank's new Operational Plan for Health 2015–2020, which aims to double ADB’s health sector operations by 2020 by supporting countries to achieve Universal Health Coverage. Besides the strategic work, one of her focus areas is to increase ADB private sector health investments, including developing sustainable public–private partnership solutions, expand ADB’s work to support regulatory convergence of pharmaceuticals and strengthen digital health infrastructure in Asia and the Pacific.

Susann believes in the need for close dialogue between the public and private sector to find innovative solutions for the changing healthcare needs of Asia and the Pacific’s population. Susann, a German national, holds a Medical Doctor degree and a PhD in medical science from the University of Heidelberg in Germany, and a Master of Public Health degree from the University of the Philippines.

Prior to joining ADB in 2009, Susann worked for research institutes, NGOs (on gender, health, human rights), public and private medical institutions in the Philippines, India, Germany and the USA, including Duke University, Baylor College, University of Washington, University of Heidelberg, and University of the Philippines. Her clinical experience is in General and Transplant Surgery, Emergency and Intensive Care, Dermatology, and Tropical Diseases. Susann was appointed as Adjunct Associate Professor at National University of Singapore, LKY School of Public Policy.

Sajid Rahman

CEO, Telenor Health

Sajid Rahman

CEO, Telenor Health


Mr. Sajid Rahman is Chief Executive Officer of Telenor Health at Telenor Group. Telenor Health is a purpose-driven company, fully owned by Telenor Group. The company is built to deliver quality, data-driven healthcare in emerging markets. Telenor Health launched its first proposition, Tonic, in Bangladesh and currently serve millions of people.

Sajid is also an experienced international banker with exposures in emerging markets of South-Asia, Africa, Middle-East and South-East Asia and worked for Standard Chartered Bank. He has board-level experience in banks, managing a wide range of businesses and taking them through M&A.

He has brought in the first Silicon Valley-based accelerator, Founder Institute, to Bangladesh. He is a director at Founder Institute. He is a mentor at Endeavor Indonesia, a US-based organization accelerating the growth of mid-size companies to billion-dollar businesses. He is an active angel investor and sits at the board of a number of technology and renewable energy companies in Asia and Europe.

He is also a speaker and author. His blogs are featured at Tech in Asia, Mattermark etc. The topics range from technology trends to impact of technology on incumbents in financial and health services.

Dr Lim Toon Wei

Senior Consultant, Department of Cardiology
National University Heart Centre Singapore

Dr Lim Toon Wei

Senior Consultant, Department of Cardiology
National University Heart Centre Singapore


Dr Lim Toon Wei graduated from the University of Sydney in 1997 with First Class Honours. He completed his physician’s training in cardiology at Westmead Hospital (Sydney, Australia) and was admitted as a Fellow of the Royal Australasian College of Physicians in 2006. Following this, he was a Cardiology Research Fellow till 2009 at Westmead Hospital, working in the area of catheter ablation for cardiac arrhythmias, particularly that of atrial fibrillation. He was awarded a PhD from the University of Sydney for this research work, which included one of the largest randomized clinical trials of atrial fibrillation ablation techniques.

In 2009, he joined the University of Ottawa Heart Institute as a Clinical Fellow in Cardiac Electrophysiology before returning to Singapore in 2010 to join the National University Heart Centre Singapore as a Consultant.

While Dr Lim sees general cardiology patients, his clinical and research interest is in cardiac arrhythmias (heart rhythm disorders). As part of his practice, he implants pacemakers, implantable cardioverter-defibrillators and cardiac resynchronisation pacemakers or defibrillators. He also performs both conventional and complex ablation procedures for all forms of arrhythmias.

Dr Lim is active in medical education and is a core faculty member of the Cardiology Senior Residency Programme. For the past 3 years, he has served in the council of the Singapore Cardiac Society as the Honorary Secretary and as the Honorary Treasurer.

Creating the Future Academy

Recording Date: Tuesday 20 June 2017
Venue: PSB Academy City Campus
6 Raffles Boulevard, Marina Square, #03-200 Singapore 039594
Guests to be seated by: 6.30pm


Derrick Chang

Chief Executive Officer, PSB Academy

Derrick Chang

Chief Executive Officer, PSB Academy


Derrick started his career in the civil service, focusing on manpower related policies and research. As a public servant, Derrick was part of a core team that was tasked by the Ministry of Manpower to form a Statutory Board – the Singapore Workforce Development Agency – to develop schemes and policies to ensure that Singapore’s core workforce was ready to thrive in the country’s competitive and open economy. He was recognized for being the Board’s top 10 employees in 2003. Derrick subsequently left the service to join PSB Corporation, to lead international business development and subsidiary management.

At PSB Corporation / PSB Academy, Derrick worked with the Senior Management on acquisition, divestment, partnership and corporate learning opportunities. Part of the work took him to China and Indonesia where he spent about 3 years helming the Academy’s local operations. Subsequent postings and opportunities took him across the different function of PSB Academy and he took on the role of Chief Operating Officer in April 2013, and assumed the role of Acting Chief Executive Officer in September 2016.

Derrick completed his Bachelor’s Degree under a National University of Singapore-University of British Columbia partnership. He subsequently undertook research in Behavioural Economics in his Honours and Masters’ Degrees

Audrey Chia

Vice President, Global Solutions, Asia Pacific
Kelly Outsourcing and Consulting Group (KellyOCG)

Audrey Chia

Vice President, Global Solutions, Asia Pacific
Kelly Outsourcing and Consulting Group (KellyOCG)


Audrey drives market and revenue growth for KellyOCG Asia Pacific and specialises in the life sciences and consumer & retail products industries. She has delivered strong and sustainable revenue gains to clients and has worked with complex client organisations across geographies and industry segments. Her role also includes taking the Client Lead for one of Kelly’s largest global accounts and leading the Asia Pacific direct sales team.

Before joining KellyOCG last November, Audrey led the strategic accounts and business development activities for the Asia Pacific region in Ernst and Young for 13 years. Prior to that, she held similar positions in KPMG and Arthur Andersen. With over 20 years of experience in the industry, Audrey has a deep understanding of business requirements and is skilled at positioning the right solutions to clients. This cuts across a wide range of business services such as audit, tax, merger & acquisitions, risk & compliance, and business & IT consulting services.

Audrey is seasoned in cultivating corporate relationships and leading organisations towards achieving business growth and profitability goals. Over the years, she has built trusted relationships with senior executives by bringing strategic views, partnerships, and expertise to help them identify issues and opportunities for business success. Audrey holds a Master of Business in International Business from Curtin University, Australia.

Feon Ang

Vice President, Talent and Learning Solutions, APAC
LinkedIn

Feon Ang

Vice President, Talent and Learning Solutions, APAC
LinkedIn


Feon is Vice President of LinkedIn’s Talent and Learning Solutions business, responsible for helping clients to engage, upskill, retain top talents across APAC.

She joined LinkedIn in January 2013, and oversees a sales organization and go-to-market strategy in the diverse set of geographies in her coverage. A seasoned business leader, Feon is particularly interested in nurturing talents, and takes an active interest in building high performance sales teams and empowering her teams to deliver outstanding results.

Prior to joining LinkedIn, Feon spent more than 13 years at Gartner in various leadership roles, where she was most recently its regional vice-president overseeing relationships with strategic client accounts across the Asia Pacific region.

Feon holds a Bachelor degree (Business) from the Nanyang Technological University in Singapore.

To view Feon’s detailed profile, click on: https://sg.linkedin.com/in/feonang

Patrick Tay

Assistant Secretary-General, National Trades Union Congress, Singapore
Member of Parliament, Singapore

Patrick Tay

Assistant Secretary-General, National Trades Union Congress, Singapore
Member of Parliament, Singapore (NCIS)


Mr Patrick Tay is the Assistant Secretary-General of NTUC. He is currently the Director of NTUC Legal Services Department, as well as the Future Jobs, Skills and Training Department. He is also the Supervising Lead for the Labour Movement’s Financial and Professional Services Cluster, as well as the Healthcare Cluster. He is the Executive Secretary of The Singapore Manual & Mercantile Workers' Union, and is Advisor to various unions. He currently co-chairs the Financial Sector Tripartite Committee with the Monetary Authority of Singapore.

As a Member of Parliament for West Coast GRC, he chairs the Government Parliamentary Committee (GPC) for Manpower and sits on the GPCs for Law and Home Affairs. He is an Advocate & Solicitor (Supreme Court of Singapore), an Associate Mediator with the Singapore Mediation Centre and Fellow of the Singapore Institute of Arbitrators. He has represented numerous unions and union members in dispute resolution, conciliation and in the Industrial Arbitration Court, and has been advocating and championing for greater outreach and protection of PMEs. He also represents the Labour Movement in tripartite workgroups to review and update employment and industrial relations legislation.

Filter controls group
Label - Radio options displayed as tabs